Skip to main content
en
en
Select your language
Close
bg
български
es
español
cs
čeština
da
dansk
de
Deutsch
et
eesti
el
ελληνικά
en
English
fr
français
ga
Gaeilge
hr
hrvatski
it
italiano
lv
latviešu
lt
lietuvių
hu
magyar
mt
Malti
nl
Nederlands
pl
polski
pt
português
ro
română
sk
slovenčina
sl
slovenščina
fi
suomi
sv
svenska
Search
Search
Search
Law
Competition Policy
Menu
Close
Menu
Back
Previous items
Next items
Home
About
News
What is competition policy?
Why is competition policy important for consumers?
Executive Vice-President Vestager
Directorate-General for Competition
Chief Competition Economist
Hearing officers
European Competition Network (ECN)
International relations
Events and Workshops
The Single Market Programme (SMP)
A competition policy fit for new challenges
See all
Antitrust & Cartels
Latest news
Cartels cases and statistics
Compliance
Contact
European Competition Network
Legislation
Leniency
Procedures
Publications
Whistleblower
See all
Mergers
Latest news
Cases
Contact
ECN Merger Working Group
Legislation
Practical Information
Procedures
Publications
Statistics
See all
State aid
Latest news
Cases
Complaints
Contact
Important Projects of Common European Interest (IPCEI)
Legislation
National Courts
Procedures
Publications
Scoreboard
Tax rulings
Ukraine
See all
Digital Markets Act
Latest news
Cases
Consultations
Events
Gatekeepers
Legislation
See all
Foreign Subsidies
Latest news
Cases
The Foreign Subsidies Regulation in a nutshell
Legislation
Practical Information
Questions and Answers
See all
Sectors
Agriculture, Food & Fisheries
Electronic communications
Energy & Environment
Financial services
Information Communication Technologies (ICT)
Media
Motor vehicles
Pharmaceuticals & Health services
Postal services
Professional services
Sports
Transport & Tourism
See all
Home
sectors_pharmaceuticals_2024_pharmaceuticals_report_monitoring_advocacy_actions_2018-2022.pdf
sectors_pharmaceuticals_2024_pharmaceuticals_report_monitoring_advocacy_actions_2018-2022.pdf
General publications
16 November 2023
sectors_pharmaceuticals_2024_pharmaceuticals_report_monitoring_advocacy_actions_2018-2022.pdf
